MCP-1/CCL2 is associated with increased recruitment of pro-tumorigenic macrophages to TME in multiple cancers [40] and is similarly believed to play an important role in immune cell trafficking to the tumor site in UM [23,41]. The gene discussed is CCL2; the disease is neoplasm.